ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Zydus Lifesciences Limited clinical trials

Also known as Zydus Cadila.

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 103 studies whose lead sponsor is Zydus Lifesciences Limited or one of 4 companies grouped under it. 9 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 28, 2026.

Our grouping of 5 registry names, not the registry’s. See them and correct one ↓

Compare Zydus Lifesciences with Gilead Sciences and GlaxoSmithKline →

Pipeline: 1 program

Each counted once: 1 with a study Zydus Lifesciences Limited leads registered in the last two years.

  • Phase 4 (approved, new studies)

The 1 program — sign in to see the list, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Zydus Lifesciences Limited’s own registered studies; Zydus Lifesciences Limited’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Zydus Lifesciences Limited’s studies test, most open studies first — 32 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 32; every drug is on its own page, and each page lists its sponsors.

Coming up

4 of Zydus Lifesciences Limited’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 2D
  3. J’27
  4. F
  5. M
  6. 1A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. 1O
  13. N

Add all 4 to your calendar (.ics) → With an account.

All 103 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now99%
  • Under way, not recruiting22%
  • Completed5654%
  • Stopped early3534%Terminated 28 · Withdrawn 4 · Suspended 3
  • Status unknown or other11%

Phase

  • Phase 241
  • Phase 135
  • Phase 327
  • Phase 42

Where

  • United States80
  • India20
  • Canada17
  • Belgium8
  • France8
  • Poland8

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 1019
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 226

By the year each study started; 12 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Zydus Lifesciences Limited.

  • Spectrum Pharmaceuticals, Inc
    Acquired — became part of Zydus Lifesciences Limited, Jun 16, 2026 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    60 studies →
  • Zydus Lifesciences Limited
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    21 studies
  • Zydus Therapeutics Inc.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    19 studies →
  • Sentynl Therapeutics, Inc.
    Acquired — became part of Zydus Lifesciences Limited, Jan 19, 2017 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Zydus Worldwide DMCC
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Zydus Lifesciences Limited leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 103. Browse all 103 →